ResearcherSecond Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityNo recent work listed
Zhenzhai Cai
Matched on ORCID iD 0000-0002-8259-5049; OpenAlex author ID A5085652878. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper
Papers 5
- Girdin influences pancreatic cancer progression by regulating c-MYC expression. Last author DOI 10.4149/neo_2021_210518n681↗
- High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients. Last author DOI 10.1007/s12094-018-02006-6↗
- High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. Last author DOI 10.3892/ijo.2016.3828↗
- Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/or.2015.4353↗
- Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells. Last author DOI 10.1186/1477-7819-12-404↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhanxiong Xue · 4 shared papers, 2014–2019 · strength 0.28
- Paper High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer pa… DOI 10.1007/s12094-018-02006-6↗
- Paper High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. DOI 10.3892/ijo.2016.3828↗
- Paper Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2015.4353↗
- Na Shan · 1 shared paper, 2022 · strength 0.19
- Yun He · 2 shared papers, 2016–2017 · strength 0.12
- Yunfeng Shan · 2 shared papers, 2016–2017 · strength 0.12
- Ling Yu · 1 shared paper, 2019 · strength 0.11
- Xiang Zhou · 1 shared paper, 2014 · strength 0.04
- Zhiqiang Zheng · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.